← Back to Health Technology

Pharmaceuticals: Major

Industry Overview

Stock Screener

Select filters to narrow down the 14 companies below

14 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

Roche Holding AG

RHHVF

Roche Holding AG

RHHVF
Market Cap $342.28B
Dividends 2.9%
P/E Ratio 20.8
Revenue $29.7B -6.1%
Net Income $5.47B +171.1%
Profit Margin +18.4%
View Stock

Roche Holding AG - ADR

RHHBY

Roche Holding AG - ADR

RHHBY
Market Cap $342.28B
Dividends 2.9%
P/E Ratio 20.8
Revenue $29.7B -6.1%
Net Income $5.47B +171.1%
Profit Margin +18.4%
View Stock

Roche Holding AG

RHHBF

Roche Holding AG

RHHBF
Market Cap $342.28B
Dividends 2.9%
P/E Ratio 20.8
Revenue $29.7B -6.1%
Net Income $5.47B +171.1%
Profit Margin +18.4%
View Stock

Astrazeneca plc - ADR

AZN

Astrazeneca plc - ADR

AZN
Market Cap $294.4B
Dividends 1.8%
P/E Ratio 25.5
Revenue $15.5B +4.1%
Net Income $2.33B +55.1%
Profit Margin +15.0%
View Stock

AstraZeneca PLC

AZNCF

AstraZeneca PLC

AZNCF
Market Cap $294.4B
Dividends 1.8%
P/E Ratio 25.5
Revenue $15.5B +4.1%
Net Income $2.33B +55.1%
Profit Margin +15.0%
View Stock

Novartis AG - ADR

NVS

Novartis AG - ADR

NVS
Market Cap $293.94B
Dividends 3.0%
P/E Ratio 22.0
Revenue $12.9B -5.6%
Net Income $3.09B -15.5%
Profit Margin +24.1%
View Stock

Novartis AG

NVSEF

Novartis AG

NVSEF
Market Cap $293.94B
Dividends 3.0%
P/E Ratio 22.0
Revenue $12.9B -5.6%
Net Income $3.09B -15.5%
Profit Margin +24.1%
View Stock

Novo Nordisk A/S Class B

NONOF

Novo Nordisk A/S Class B

NONOF
Market Cap $214.13B
Dividends 3.6%
P/E Ratio 11.7
Revenue $96.8B +24.0%
Net Income $48.6B +67.2%
Profit Margin +50.2%
View Stock

Sanofi - ADR

SNY

Sanofi - ADR

SNY
Market Cap $106.21B
Dividends 5.4%
P/E Ratio 19.1
Revenue $11.2B +6.0%
Net Income $1.61B -13.8%
Profit Margin +14.4%
View Stock

Sanofi

SNYNF

Sanofi

SNYNF
Market Cap $106.21B
Dividends 5.4%
P/E Ratio 19.1
Revenue $11.2B +6.0%
Net Income $1.61B -13.8%
Profit Margin +14.4%
View Stock

Abattis Bioceuticals Corp.

ATTBF

Abattis Bioceuticals Corp.

ATTBF
Market Cap $14.33K
Dividends 0.0%
P/E Ratio -0.0
Revenue $226k
Net Income -$907k
Profit Margin -400.9%
View Stock

AMAG Pharmaceuticals, Inc.

AMAG

AMAG Pharmaceuticals, Inc.

AMAG
Market Cap $
Dividends
P/E Ratio 0.0
Revenue $93.1M +10.7%
Net Income $9.7M -141.1%
Profit Margin +10.4%
Employees 440
View Stock

Akorn, Inc.

AKRX

Akorn, Inc.

AKRX
Market Cap $
Dividends
P/E Ratio 0.0
Revenue $205M
Net Income -$257M
Profit Margin -125.4%
Employees 2.23K
View Stock

Menlo Therapeutics Inc.

MNLO

Menlo Therapeutics Inc.

MNLO
Market Cap $
Dividends
P/E Ratio 0.0
Revenue $3.27M
Net Income -$24.7M
Profit Margin -756.0%
Employees 40
View Stock